Skip to main content

Advertisement

SpringerLink
Log in

Is Delayed Liver Resection Appropriate for Patients with Metachronous Colorectal Metastases?

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

In terms of timing of resection for synchronous liver metastases from colon cancer, some reports recommend leaving an interval (e.g., 3 months) after primary colorectal resection, because of reports of occasional and rapid remnant recurrence of residual liver metastases after simultaneous colorectal and liver resection (LR). For patients with metachronous liver metastasis (MLM), we prospectively examined the appropriateness of a 3-month interval to LR (i.e., delayed resection) following initial detection of hepatic lesions from the viewpoints of (1) detection of new metastases during this interval and (2) postoperative outcome.

Methods

Seventy-nine consecutive patients with modified Japanese criteria H1 class MLM (i.e., ≤4 nodules, 6 cm or less in diameter) and without obvious extrahepatic lesions, presenting between 1990 and 2008, were included in this study. Between 1990 and 2001, 52 patients were treated by LR without an interval (i.e., nondelayed group); from 2002, 27 patients were prospectively scheduled for LR at an interval of 3 months after initial detection of metastases (i.e., delayed group). During the 3-month interval, no adjuvant chemotherapy was given. Just prior to LR, patients were re-evaluated using computed tomography (CT) and deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) to exclude cases unsuitable for surgery.

Results

Out of 27 patients in the delayed group, 2 (7.4%) did not undergo LR after the 3-month interval and were excluded from the analysis: one because of multiple nodules in the bilateral lobe of the liver with pulmonary metastases and another because of para-aortic lymph node metastasis. Of the 25 patients for whom LR was indicated, 24 underwent LR as initially planned. In the remaining patient, after the 3-month interval, invasion of the tumor had occurred into the inferior vena cava (IVC) and other surgery in addition to the planned operation was required. When comparing the postoperative outcome data of the delayed group (n = 25) with the nondelayed group (n = 52), overall early recurrence within 1 year after LR was noticed in 30.9% (16/52) of the nondelayed group and 28.0% (7/25) of the delayed group; the incidence of only early extrahepatic recurrence decreased 5.1% in the delayed group (21.1% versus 16.0%, respectively). When comparing disease-free survival after liver resection, however, there was no significant difference between the groups.

Conclusions

Delayed LR for MLM patients after initial detection of hepatic lesions is of no clinical benefit. Only in cases when extrahepatic lesions with MLM are suspected could an interval make such lesions clearer and assist in deciding on a suitable management plan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254–9.

    Article  PubMed  Google Scholar 

  2. Bramhall SR, Gur U, Coldham C, et al. Liver resection for colorectal metastases. Ann R Coll Surg Engl. 2003;85:334–9.

    Article  PubMed  CAS  Google Scholar 

  3. Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut. 2006;55:1–8.

    Article  Google Scholar 

  4. Kaibori M, Iwamoto S, Ishizaki M, et al. Timing of resection for synchronous liver metastases from colorectal cancer. Dig Dis Sci. 2010;55:3262–70.

    Article  PubMed  Google Scholar 

  5. Shimizu Y, Yasui K, Sano T, et al. Treatment strategy for synchronous metastases of colorectal cancer: is hepatic resection after an observation interval appropriate? Langenbecks Arch Surg. 2007;392:535–58.

    Article  PubMed  Google Scholar 

  6. Shimizu Y, Yasui K, Sano T, et al. Validity of observation interval for synchronous hepatic metastases of colorectal cancer: changes in hepatic and extrahepatic metastatic foci. Langenbecks Arch Surg. 2008;393:181–4. Epub 2008.

    Article  PubMed  Google Scholar 

  7. Yoshidome H, Kimura F, Shimizu H, et al. Interval period tumor progression: does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases? J Gastrointest Surg. 2008;12:1391–8.

    Article  PubMed  Google Scholar 

  8. Takahashi S, Konishi M, Nakagohri T, et al. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn J Clin Oncol. 2006;36:368–75.

    Article  PubMed  Google Scholar 

  9. House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210:744–52.

    Article  PubMed  Google Scholar 

  10. Yumoto Y, Umeda M, Ohshima K, et al. Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin. Cancer Chemother Pharmacol. 1994;33:1–6.

    Article  Google Scholar 

  11. Elias D, Liberale G, Vernerey D, et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol. 2005;12:900–9.

    Article  PubMed  Google Scholar 

  12. Byam J, Reuter NP, Woodall CE, et al. Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation? Ann Surg Oncol. 2009;16:3064–9.

    Article  PubMed  Google Scholar 

  13. Carpizo DR, D’Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Lancet Oncol. 2009;10:801–9.

    Article  PubMed  Google Scholar 

  14. de Haas RJ, Wicherts DA, Adam R. Resection of colorectal liver metastases with extrahepatic disease. Dig Surg. 2008;25:461–6.

    Article  PubMed  Google Scholar 

  15. Bennett JJ, Schmidt CR, Klimstra DS, et al. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases. Ann Surg Oncol. 2008;15:1130–6.

    Article  PubMed  Google Scholar 

  16. Pawlik TM, Assumpcao L, Vossen JA, et al. Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for colorectal metastases. Ann Surg Oncol. 2009;16:371–8.

    Article  PubMed  Google Scholar 

  17. Marti J, Mondolo MM, Fuster J, et al. Prognostic factors and time-related changes Influence results of colorectal liver metastases surgical treatment: a single-center analysis. World J Gastroenterol. 2009;15:2587–94.

    Article  PubMed  Google Scholar 

  18. Konopke R, Kersting S, Distler M, et al. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int. 2009;29:89–102.

    Article  PubMed  Google Scholar 

  19. Kokudo N, Imamura H, Sugawara Y, et al. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg. 2004;11:84–91.

    Article  PubMed  Google Scholar 

  20. Tanaka K, Shimada H, Fujii Y, et al. Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg. 2004;389:371–9.

    Article  PubMed  Google Scholar 

  21. Elias D, Goere D, Boige V, et al. Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin. Ann Surg Oncol. 2007;14:3188–94.

    Article  PubMed  Google Scholar 

  22. Chiappa A, Bertani E, Makuuchi M, et al. Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases. Hepatogastroenterology. 2009;56:829–34.

    PubMed  Google Scholar 

  23. Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol. 2008;26:4906–11.

    Article  PubMed  CAS  Google Scholar 

  24. Tsutsumi S, Yamaguchi S, Tsuboi K, et al. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer. Hepatogastroenterology. 2008;55:1419−22.

    PubMed  CAS  Google Scholar 

  25. Elias D. Impact of tumor doubling time on the therapeutic strategy: application to so-called synchronous metastases of colorectal cancers. Ann Chir. 1998;52:413–20.

    PubMed  CAS  Google Scholar 

  26. Cohen SJ, Punt CJ, Iannotti N, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009;20:1223–9.

    Article  PubMed  CAS  Google Scholar 

  27. Uchikura K, Ueno S, Takao S, et al. Perioperative detection of circulating cancer cells in patients with colorectal hepatic metastases. Hepatogastroenterology. 2002;49:1611–4.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology & Digestive Surgery, Field of Oncology, Course of Advanced Therapeutics, Kagoshima University Graduate School of Medicine & Dental Sciences, Kagoshima, Japan

    Shinichi Ueno MD, Masahiko Sakoda MD, Masaki Kitazono MD, Satoshi Iino MD, Hiroshi Kurahara MD, Koji Minami MD, Kei Ando MD, Yukou Mataki MD, Kosei Maemura MD, Sumiya Ishigami MD & Shoji Natsugoe MD

Authors
  1. Shinichi Ueno MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masahiko Sakoda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaki Kitazono MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satoshi Iino MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Kurahara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Koji Minami MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kei Ando MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yukou Mataki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kosei Maemura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sumiya Ishigami MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shoji Natsugoe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shinichi Ueno MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueno, S., Sakoda, M., Kitazono, M. et al. Is Delayed Liver Resection Appropriate for Patients with Metachronous Colorectal Metastases?. Ann Surg Oncol 18, 1104–1109 (2011). https://doi.org/10.1245/s10434-010-1418-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1418-0

Keywords

Search

Navigation